Dr. Pankaj Gandhi, Dr. J. R. Parekh (2005) Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese women. Clinworld (P) Ltd.
24 obese female subjects, aged 25-35 yrs, and with body mass index ranging from 28 to 45 (I degree to III degree obesity) were enrolled in the study. Physical examination including blood pressure, weight, BMI and % body fat measurement were done.
Forskolin demonstrated a significant increase in lean body mass with a corresponding reduction in body weight, BMI and fat content. There was no effect on hormonal levels or BMD. The good tolerability of ForsLean® along with its weight loss efficacy makes it an attractive option in the treatment of obesity.
Sabinsa Wins Again: Federal Court Denies Creative Compounds Motion
Listen to a brief video on ForsLean®
View past and recent advertisements
Innovative Ingredients Paper Weight loss approach
Sabinsa calls to readers' attention that some of the products, protocols and uses of the products described here in are or may be subject to various restrictions or limitations because of patents, exclusive or nonexclusive licenses, confidentiality agreements and other intellectual property or equivalent rights. Readers are advised to make an early and thorough investigation and inquiry into any product, protocol or use in which they may be interested, to see if any such rights might be applicable. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.